Your search for evid returned 3 results

Pharmacotherapeutic issues associated with generic substitutions of antiseizure medications may not only be the result of the FDA’s bioequivalence standards.

The study aimed to identify medication classes and specific SSRIs that provide high rates of remission as well as a low risk of adverse events when used in the treatment of panic disorder with or without agoraphobia.

The retrospective review included 6 pediatric patients younger than 12 months of age in the neonatal intensive care unit.